Semaglutide reaches patients in the United States two very different ways, and the price gap is wide enough to drive the whole decision. One route is the brand medicine made by the manufacturer, reviewed by the FDA, and sold as a prefilled pen or a labeled vial. The other is compounded semaglutide, mixed by a pharmacy and usually sold through a telehealth clinic on a flat monthly cash plan. The molecule is nominally the same. The regulation, the label, the dose measurement and the legal footing are not.
The compounded vs brand semaglutide choice is easier once you take it in order: what really differs, why the cash price differs, whether the compounded version is legal and effective, how the dosing risk changes, and how to check a single clinic before you hand over a card.
Start by naming what you are optimizing for
People arrive at this question with different constraints, and the right answer changes with the constraint. Write down which of these matters most to you before you read any pricing.
- Lowest monthly cash outlay. No insurance involved, and you want the smallest number now.
- Insurance coverage. You have a plan that may cover a brand GLP-1, and you are willing to work through paperwork.
- Regulatory certainty. You want a product the FDA has reviewed for safety, effectiveness and quality, with a known label and a traceable recall path.
- Dose flexibility. You want a smaller starting dose than the standard schedule, or you need to hold at an in between step.
- Supply stability. You do not want to change formulations or suppliers halfway through a titration.
- Support and access. You want a clinician who answers messages, adjusts doses and orders labs.
If regulatory certainty is your top constraint, the decision is close to made and the rest of the work is cost and coverage. If cash price rules, the real work is judging quality and legal footing on the compounded side.
What actually differs between compounded and brand-name semaglutide
Brand semaglutide is sold under specific names for specific approved uses: Ozempic and Rybelsus for type 2 diabetes, and Wegovy for weight management. Those products carry an FDA-approved label, a fixed titration schedule, and a manufacturer that answers for every batch. Compounded semaglutide has no brand name and no approved label. It is prepared by a pharmacy, often as a multi dose vial with syringes, and sometimes mixed with additives such as vitamin B12.
Compounding itself is a normal, long standing part of pharmacy practice. The FDA describes compounded drugs as combined or altered by a licensed pharmacist or physician, and states plainly that they are not FDA-approved and have not been reviewed for safety, effectiveness or quality.
| What you are checking | Brand-name semaglutide | Compounded semaglutide |
|---|---|---|
| Regulatory review | Reviewed and approved for named uses | Not FDA-approved; not reviewed for safety, effectiveness or quality |
| Names you will see | Ozempic, Rybelsus, Wegovy | Compounded semaglutide, sometimes with B12 or other additives |
| How it arrives | Prefilled pen or manufacturer-filled device with an approved label | Usually a vial plus syringes, dosed by volume or by units |
| Who prepares it | The manufacturer, with the finished drug under FDA oversight | A 503A pharmacy or a 503B outsourcing facility |
| Insurance | Can be covered, usually after prior authorization | Almost always cash pay |
| Dose steps | Fixed strengths in the approved schedule | May include micro doses or non-standard strengths |
| Recall path | Manufacturer and FDA channels | Varies by pharmacy and is harder to trace |
Why compounded semaglutide is cheaper
The savings are not a discount on the same product. A compounder does not repeat the clinical trial program, does not fund the approved device, and does not carry the brand’s marketing or rebate structure. It buys active pharmaceutical ingredient, prepares a sterile solution, and fills a plain vial. Most compounded plans also skip the pharmacy benefit entirely, so no rebate flows to a middleman and the clinic can quote one flat cash number.
That flat number is also a bundle. On many telehealth plans the monthly fee covers the clinician visit, the medicine, the syringes and messaging support, which makes a direct comparison with a pharmacy copay awkward. Read what the fee includes before you treat it as a like for like price.
Across the clinics we track, the cash range for semaglutide plans runs from $99 to $499 a month, with a median of $179.
No provider matches that filter. .
See every provider we track, with filters and sorting
Is compounded semaglutide legal, and what changed
Federal law limits compounders from making copies of an approved drug. Two narrow paths have carried most compounded GLP-1 volume: the drug being listed on the FDA drug shortage list, or a documented clinical need for a change for an individual patient, such as a different concentration or the removal of an ingredient the patient cannot tolerate.
The shortage path closed. The FDA removed semaglutide and tirzepatide from its shortage list and set end dates after which state licensed pharmacies and outsourcing facilities were expected to stop producing copies. Some clinics kept selling compounded versions on the argument that a personalized dose or an added ingredient makes the preparation something other than a copy. That argument is contested, and the FDA has warned about unapproved GLP-1 products sold for weight loss.
Why it matters: if your supply depends on a legal position that may not hold, plan for the possibility that your source stops shipping mid titration.
Ask any clinic one direct question: is the medicine prepared by a 503A pharmacy or a 503B outsourcing facility? A 503A pharmacy compounds for individual prescriptions under state board oversight. A 503B outsourcing facility registers with the FDA, follows current good manufacturing practice requirements, and is subject to FDA inspection. Neither makes an approved product, but the quality systems are not equivalent.
Also confirm the active ingredient by name. The FDA has stated that semaglutide salt forms, such as semaglutide sodium and semaglutide acetate, are different substances from the semaglutide in approved products and do not meet the requirements for compounding. Anything sold as a research peptide, not for human use, sits outside pharmacy practice entirely and carries no sterility or potency assurance.
Best on trust and safety
Certification, prescribing and transparency.
- Form Health8.6 / 10
- Levity8.5 / 10
- Willow8.2 / 10
- Allara Health8.2 / 10
- Noom Med8.2 / 10
Best on clinical care
The quality of the medical side.
- Form Health8.7 / 10
- 9amHealth8.5 / 10
- Marek Health8.4 / 10
- Teladoc Health8.3 / 10
- Defy Medical8.2 / 10
Ranked from our own scores, recomputed as data changes. Providers cannot pay for a place.
Is compounded semaglutide as effective as the brand?
The honest answer is that nobody has tested it head to head. The weight and glucose results people quote come from trials of the approved products, run at known strengths with verified potency. A compounded preparation that truly contains the labeled amount of semaglutide should behave like the same amount of brand semaglutide, because it is the same molecule acting on the same GLP-1 receptor. The uncertainty is not the pharmacology; it is whether every vial contains what the label claims.
Independent testing of compounded GLP-1 samples has found variation in potency and impurities in some products, which is exactly what an approval process is designed to prevent. That variation matters most for people who are titrating, because a weaker than expected vial reads as a plateau and a stronger one reads as sudden intolerance.
The FDA states that compounded drugs are not FDA-approved and have not been evaluated for safety, effectiveness or quality. (FDA)So the answer to the common question, is compounded semaglutide better than regular semaglutide, is no. It can be cheaper and it can be dosed more flexibly. It is not a stronger or improved version of the same drug.
Are all compounded semaglutide products the same?
No, and this is where buyers get caught. Two vials labeled compounded semaglutide can differ in concentration, in additives, in the syringe supplied and in the testing behind them. A vial at one concentration may need a completely different volume than a vial at another, even for the identical milligram dose.
The most consequential difference is how you measure the dose. A brand pen dials a set milligram amount. A compounded vial usually asks you to draw a volume, and clinics often write instructions in units on an insulin syringe, where 100 units equals 1 mL. That conversion is where ten fold errors happen.
The FDA has received reports of dosing errors with compounded semaglutide, including patients drawing up several times the intended dose. (FDA)If your instructions are written in units and the vial is labeled in milligrams per millilitre, convert once, write it down, and confirm it with the prescriber before your first injection.
Dose to syringe units converter
Compounded vials are dosed in mg, insulin syringes in units. Dose-to-volume conversion is a frequent source of confusion when a prescription is written in milligrams but supplied in a fixed concentration.
Educational math only. Always confirm your dose and draw with the dispensing pharmacist; concentrations differ between pharmacies and even between refills.
Signals worth treating as red flags:
- The pharmacy will not tell you its name, its state license or whether it is 503A or 503B.
- No certificate of analysis for potency and sterility is available on request.
- The vial or paperwork lists semaglutide sodium or semaglutide acetate.
- Instructions give units with no stated concentration in mg per mL.
- The product is sold without any clinician involvement, or arrives from an unnamed overseas shipper.
- Marketing language promises a specific pound loss or calls the product identical to Ozempic.
Compounded and brand tirzepatide, and how the two molecules differ
The same split exists for tirzepatide, sold as Mounjaro for type 2 diabetes and Zepbound for weight management and for obstructive sleep apnea in adults with obesity. Compounded tirzepatide raises every issue above, with the added wrinkle that it is a newer molecule with a shorter real world safety record outside the trials.
Semaglutide is a GLP-1 receptor agonist, an incretin based medicine that mimics a gut hormone released after eating. Tirzepatide acts on two receptors, GIP and GLP-1. In trials of the approved products, average weight reduction was larger with tirzepatide, though those studies enrolled different populations and cannot be read as a promise for any one person. Side effect profiles are broadly similar, and both are injected once weekly.
A practical point for the compounded route: switching molecules means a new titration from a low dose, so a mid course change usually costs you weeks of progress. Decide on the molecule before you optimize on price.
No provider matches that filter. .
See every provider we track, with filters and sorting
Side effects, warnings and monitoring on either route
The side effect picture comes from the approved products and applies to the molecule, so it carries over to a compounded version that genuinely contains it. Nausea, vomiting, diarrhea, constipation, burping, indigestion and injection site reactions are the common complaints, and they cluster in the first weeks and after each dose increase.
Serious risks documented on approved labels include pancreatitis, gallbladder disease including gallstones, kidney injury from dehydration after prolonged vomiting, worsening diabetic retinopathy in some patients, and delayed stomach emptying that can raise aspiration risk during anesthesia. Approved semaglutide and tirzepatide products carry a boxed warning about thyroid C-cell tumors seen in rodents, and are contraindicated in people with a personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2. None of these products is for type 1 diabetes or for treating diabetic ketoacidosis.
Interactions and monitoring worth raising with a clinician:
- Insulin or a sulfonylurea raises hypoglycemia risk; doses of those medicines often need review.
- Slowed gastric emptying can change how quickly oral medicines are absorbed.
- Oral contraceptive absorption can be affected by vomiting; ask about backup contraception.
- Pregnancy, planned pregnancy and breastfeeding are reasons not to start.
- A history of pancreatitis, gastroparesis or severe reflux changes the risk calculation.
- Weight, blood pressure and, in diabetes, A1c and glucose patterns deserve regular checks.
Call a clinician promptly for severe or persistent abdominal pain, repeated vomiting, signs of dehydration, right upper abdominal pain with fever, vision changes, or symptoms of very low blood sugar. On the compounded route, ask up front who you contact after hours, because there is no manufacturer support line behind the vial.
Do the year math, not the month math
Monthly pricing hides the shape of a year. Many compounded plans quote a low introductory month and step up as your dose rises, and some bill quarterly at a lower per month rate. On the brand side, a manufacturer self pay channel, a copay card with an annual cap, or a deductible that resets in January can all move your true annual number by a wide margin.
Total twelve months on each route, including the clinician fee, syringes, shipping and any lab work you will pay for. Then compare.
What a year actually costs
Programmes quote a monthly headline. Add the medication, the labs and the renewal price and the real number is usually different.
Advertised prices change often and intro pricing rarely lasts. Ask what the renewal rate is before you commit to a plan.
The insurance route: prior authorization, step therapy and deductibles
Compounded GLP-1 plans are cash pay, so insurance only enters the picture on the brand side. Whether a plan pays depends less on your diagnosis than on how the plan was written by your employer or insurer.
- Exclusions. Many plans exclude drugs used for weight loss outright, no matter what the chart says.
- Prior authorization. Expect a form asking for BMI, documented weight history, and prior attempts at diet and activity.
- Step therapy. Some plans require a cheaper medicine first, or a lifestyle program enrollment.
- Deductible phase. Before the deductible is met you may pay the full negotiated price, which is why January invoices shock people.
- Copay versus coinsurance. A flat copay is predictable; coinsurance at a percentage of a four figure list price is not.
- Medicare. Part D plans have long excluded drugs used for weight loss, though coverage can apply when a product is prescribed for another approved use.
If you have coverage, price the brand through your plan before assuming compounded is cheaper. A covered brand copay can undercut a cash plan, and it comes with an approved label. If a prior authorization is denied, ask for the specific denial reason in writing, since most appeals turn on one missing piece of documentation.
No provider matches that filter. .
See every provider we track, with filters and sorting
Who each route tends to suit
Brand semaglutide or tirzepatide tends to suit people with plan coverage, people who want the certainty of an approved product and device, anyone with a complex medical history, and anyone who would struggle to draw an accurate dose from a vial.
Compounded routes tend to attract people with no coverage and a hard monthly ceiling, and people who want an unusually low starting dose. If that is you, treat quality checks as the price of entry: named pharmacy, stated concentration, documented testing, and a clinician you can actually reach.
Quick tip: whichever route you pick, keep a simple log of dose, date and side effects so a dose change is a decision rather than a guess.
How to check one clinic before you pay
- Confirm the clinician is licensed in your state and will review your history, not just a form.
- Ask which pharmacy prepares the medicine, and whether it is a 503A pharmacy or a 503B outsourcing facility.
- Ask for the exact active ingredient and reject salt forms such as semaglutide sodium or acetate.
- Request the concentration in mg per mL and the milligram amount of each dose in writing.
- Ask for a recent certificate of analysis covering potency and sterility.
- Get the full price ladder for every dose step, plus shipping, syringes and refill timing.
- Check the cancellation terms, the auto renewal date and what happens to unused vials.
- Ask how cold shipments are handled, and what they do if a package arrives warm or late.
- Ask what happens if you need to move to a brand product, and whether they will write that prescription.
Two answers tell you most of what you need: how specific the clinic gets about the pharmacy and the concentration, and how quickly a human replies before you have paid anything.
Before You Pay a Compounded Clinic
- Clinician is licensed in your state and reviews your full history
- Pharmacy is named and confirmed as 503A or 503B
- Active ingredient is semaglutide - not semaglutide sodium or acetate
- Concentration stated in mg per mL with each dose in mg in writing
- Certificate of analysis for potency and sterility available on request
- Full price ladder for every dose step, plus shipping and syringes
- Cancellation terms, auto-renewal date, and cold-chain handling explained
Best on support
What happens when something goes wrong.
- Amazon One Medical7.5 / 10
- Found7.5 / 10
- FuturHealth7.4 / 10
- Form Health7 / 10
- Marek Health7 / 10
Best on ease of use
Signing up, reordering, getting hold of someone.
- Amazon One Medical8.5 / 10
- Found8.4 / 10
- Form Health7.5 / 10
- Hims7.5 / 10
- OrderlyMeds7.5 / 10
Ranked from our own scores, recomputed as data changes. Providers cannot pay for a place.
Authoritative sources
- FDA guidance on unapproved GLP-1 drugs used for weight loss
- FDA questions and answers on human drug compounding
- NIH information on prescription medications for overweight and obesity
This content is for general informational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified clinician or pharmacist about your situation, and seek urgent care or call your local emergency number for severe or worsening symptoms.